Intimation of Board Meeting dated November 01, 2018
Certification under Regulation 40(9) and (10)- September 2018
Grievance Redressal Mechanism – September 2018
Certification under Regulation 7- September 2018
Reconciliation of Share Capital- September 2018
Intimation of Schedule of Investor Conference
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we would wish to inform you that the Senior Management of the Company will be participating at the ‘JP Morgan, 2018 India Investor Summit’ to be held at New Delhi on September 19, 2018 and September 20, 2018.
Closure of “Trading Window”
In accordance with the Company’s Policy on Insider Trading, the date of commencement of closing of “Trading Window” shall be from September 15, 2018 and shall end 48 hours after public announcement of the Audited / Un-Audited Financial Results for the Second Quarter and Half Year ended September 30, 2018.
Notice of Book Closure and Record Date
The Register of Members and Share Transfer Book of the Company will remain closed from Thursday, August 2, 2018 to Wednesday, August 8, 2018 (both days inclusive) for the purpose of 59th Annual General Meeting and for taking on record the Shareholders for the purpose of payment of Dividend, if approved at the Annual General Meeting, for the year ended March 31, 2018.
Dividend, if approved at the Annual General Meeting, will be paid to all those Members whose names appear in the Company’s Register of Members and to those persons whose names appear as beneficial owner (as per the details to be furnished by the Depositories in respect of shares held in dematerialized form) as at the close of business hours on Wednesday, August 1, 2018.
Intimation of Board Meeting
A meeting of the Board of Directors of the Company will be held on Tuesday, August 7, 2018 at 18:00 hours at Conference Room, GlaxoSmithKline Consumer Healthcare Limited, Patiala Road, Nabha -147201 to, inter-alia, consider and take on record the unaudited Financial Results for the quarter ended June 30, 2018 with Limited Review by Auditors.